{"id":"https://openalex.org/W183293552","doi":null,"title":"Differentiating incretin-based therapies for population-based health care.","display_name":"Differentiating incretin-based therapies for population-based health care.","publication_year":2011,"publication_date":"2011-03-01","ids":{"openalex":"https://openalex.org/W183293552","mag":"183293552","pmid":"https://pubmed.ncbi.nlm.nih.gov/21517657"},"language":"en","primary_location":{"id":"pmid:21517657","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21517657","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109899153","display_name":"Dave Calabrese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dave Calabrese","raw_affiliation_strings":["MedMetrics Health Partners, 100 Century Dr, Worcester, MA 01606, USA. calabreseds@charter.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedMetrics Health Partners, 100 Century Dr, Worcester, MA 01606, USA. calabreseds@charter.net","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5109899153"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6162,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.69126318,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"17","issue":"2 Suppl","first_page":"S52","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9480000138282776},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9769999980926514},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9599999785423279},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.8960000276565552},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8669999837875366},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8100000023841858},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/satiety","display_name":"satiety","score":0.7919999957084656},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.48100000619888306},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9430000185966492}],"concepts":[{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.9402214884757996},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8312017917633057},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.7170575261116028},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6259645223617554},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6118035316467285},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6084938645362854},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.6014026403427124},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.5058881640434265},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.47354739904403687},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.47290194034576416},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.4651670455932617},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.44580402970314026},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4417873024940491},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.41210657358169556},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3942321836948395},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3114434480667114},{"id":"https://openalex.org/C2779422922","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Stomach","level":2,"score":0.04120895266532898},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002319","descriptor_name":"Cardiovascular System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002985","descriptor_name":"Clinical Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:21517657","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21517657","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},{"id":"mag:183293552","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21517657","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2098083442","https://openalex.org/W1984177371","https://openalex.org/W1220137049","https://openalex.org/W1977574777","https://openalex.org/W2068059840","https://openalex.org/W2395004214","https://openalex.org/W1545603700","https://openalex.org/W2064437324","https://openalex.org/W2000074754","https://openalex.org/W2032254224"],"abstract_inverted_index":{"Incretin":[0],"hormones,":[1],"such":[2,52],"as":[3,17,19,53],"glucagon-like":[4],"peptide-1":[5],"(GLP-1),":[6],"play":[7],"a":[8,73,106,123],"crucial":[9],"role":[10],"in":[11,72,193,198],"modulating":[12],"insulin":[13],"and":[14,24,39,57,70,79,92,137,166,170],"glucagon":[15],"secretion,":[16],"well":[18],"regulating":[20],"appetite,":[21],"gastric":[22,164],"emptying,":[23,165],"pancreatic":[25],"beta":[26,144],"cell":[27,145],"function.":[28],"The":[29],"pathophysiology":[30],"of":[31,67,109,126],"type":[32],"2":[33],"diabetes":[34,136],"mellitus":[35],"(T2DM)":[36],"is":[37],"complex":[38],"includes":[40],"impaired":[41],"incretin":[42,68],"response,":[43],"among":[44],"other":[45],"metabolic":[46],"abnormalities.":[47],"Incretin-based":[48,140],"treatments":[49,141],"for":[50,151,190],"T2DM,":[51,196],"GLP-1":[54,89,100,113,120,127,154,181],"receptor":[55,90,114,155,182],"agonists":[56,91,115,156,183],"dipeptidyl":[58],"peptidase-4":[59],"(DPP-4)":[60],"inhibitors,":[61],"mimic":[62],"or":[63,206],"prolong":[64],"the":[65,88,93,119],"actions":[66],"hormones":[69],"function":[71],"glucose-dependent":[74],"manner,":[75],"thereby":[76,104],"reducing":[77],"hyperglycemia":[78],"avoiding":[80],"hypoglycemia.":[81,210],"There":[82],"are":[83,175,207],"important":[84],"mechanistic":[85],"differences":[86],"between":[87],"DPP-4":[94,96,102,178],"inhibitors.":[95,179],"inhibitors":[97],"protect":[98],"endogenous":[99],"from":[101,203],"degradation,":[103],"achieving":[105,122],"physiologic":[107],"level":[108,125],"GLP-1.":[110],"In":[111],"contrast,":[112],"act":[116],"directly":[117],"on":[118,135],"receptor,":[121],"pharmacologic":[124],"activity.":[128],"These":[129],"different":[130,133],"mechanisms":[131],"yield":[132],"effects":[134],"weight":[138,204],"loss.":[139],"may":[142,157],"improve":[143,168],"function,":[146],"and,":[147],"while":[148],"not":[149],"indicated":[150],"these":[152,173],"effects,":[153],"also":[158],"promote":[159],"satiety,":[160],"reduce":[161],"weight,":[162],"slow":[163],"possibly":[167],"hypertension":[169],"triglyceride":[171],"levels;":[172],"characteristics":[174],"absent":[176],"with":[177,195],"Therefore,":[180],"can":[184],"be":[185],"an":[186],"appropriate":[187],"clinical":[188],"choice":[189],"glycemic":[191],"control":[192],"patients":[194],"especially":[197],"those":[199],"who":[200],"would":[201],"benefit":[202],"loss":[205],"prone":[208],"to":[209]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}